Technical Analysis for PETQ - PetIQ, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 41.68 | 6.49% | 2.54 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Historical PETQ trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Gilligan's Island Sell Setup | Bearish Swing Setup | 6.49% | |
| New 52 Week Closing High | Bullish | 6.49% | |
| Expansion Breakout | Bullish Swing Setup | 6.49% | |
| Pocket Pivot | Bullish Swing Setup | 6.49% | |
| Volume Surge | Other | 6.49% | |
| New 52 Week High | Strength | 6.49% | |
| Multiple of Ten Bearish | Other | 6.49% | |
| BB Squeeze Ended | Range Expansion | 6.49% | |
| Above Upper BB | Strength | 6.49% | |
| Gapped Up | Strength | 6.49% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | 9 minutes ago |
| New 52 Week High | 9 minutes ago |
| Up 5% | 9 minutes ago |
| Possible Pocket Pivot | 44 minutes ago |
| 60 Minute Opening Range Breakout | about 2 hours ago |
Get a Trading Assistant
- Earnings date: 02/25/2021
PetIQ, Inc. Description
PetIQ, Inc. is engaged in manufacturing and distributing pet medication and health and wellness products to the retail channel in the United States. The Company provides retail stores with third-party brands, including Frontline Plus, Heartgard Plus, PetAction Plus, Advecta II, Pet Lock Plus, Pet Lock Max, TruProfen and Heartshield. It distributes the products through veterinarian, retail and e-commerce channels. The Company offers its products in a range of categories, including Rx Medications, OTC Medications and Supplies, and Health and Wellness Products. Rx Medications offering includes heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics and other specialty medications. The Company manufactures Heart Shield Plus, version of Heartgard Plus, which prevents heartworm infection in dogs. The Company also manufactures TruProfen, the version of Rimadyl, which treats arthritis in dogs. OTC Medications and Supplies include flea and tick control products.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Retail Stores Pain Diabetes Antibiotic Thyroid Dogs Control Products Antibiotics Arthritis Retail Channel Wellness Products Zoonoses E Commerce Channels Wellness Dirofilaria Immitis Rimadyl
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 41.15 |
| 52 Week Low | 22.73 |
| Average Volume | 266,589 |
| 200-Day Moving Average | 33.38 |
| 50-Day Moving Average | 35.56 |
| 20-Day Moving Average | 35.81 |
| 10-Day Moving Average | 36.60 |
| Average True Range | 1.50 |
| ADX | 17.71 |
| +DI | 37.14 |
| -DI | 11.43 |
| Chandelier Exit (Long, 3 ATRs ) | 36.64 |
| Chandelier Exit (Short, 3 ATRs ) | 37.61 |
| Upper Bollinger Band | 38.25 |
| Lower Bollinger Band | 33.38 |
| Percent B (%b) | 1.18 |
| BandWidth | 13.59 |
| MACD Line | 0.58 |
| MACD Signal Line | 0.29 |
| MACD Histogram | 0.2936 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 42.71 | ||||
| Resistance 3 (R3) | 42.98 | 42.07 | 42.12 | ||
| Resistance 2 (R2) | 42.07 | 41.16 | 41.93 | 41.92 | |
| Resistance 1 (R1) | 40.60 | 40.60 | 40.15 | 40.33 | 41.72 |
| Pivot Point | 39.69 | 39.69 | 39.46 | 39.55 | 39.69 |
| Support 1 (S1) | 38.22 | 38.78 | 37.77 | 37.95 | 36.56 |
| Support 2 (S2) | 37.31 | 38.22 | 37.17 | 36.36 | |
| Support 3 (S3) | 35.84 | 37.31 | 36.17 | ||
| Support 4 (S4) | 35.57 |
